1. Home
  2. EYEN vs PBM Comparison

EYEN vs PBM Comparison

Compare EYEN & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • PBM
  • Stock Information
  • Founded
  • EYEN 2014
  • PBM 1994
  • Country
  • EYEN United States
  • PBM Canada
  • Employees
  • EYEN N/A
  • PBM N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • PBM
  • Sector
  • EYEN Health Care
  • PBM
  • Exchange
  • EYEN Nasdaq
  • PBM NYSE
  • Market Cap
  • EYEN 9.2M
  • PBM 7.5M
  • IPO Year
  • EYEN 2018
  • PBM N/A
  • Fundamental
  • Price
  • EYEN $0.06
  • PBM $1.79
  • Analyst Decision
  • EYEN Hold
  • PBM
  • Analyst Count
  • EYEN 4
  • PBM 0
  • Target Price
  • EYEN $2.00
  • PBM N/A
  • AVG Volume (30 Days)
  • EYEN 49.5M
  • PBM 5.4M
  • Earning Date
  • EYEN 11-12-2024
  • PBM 02-02-2025
  • Dividend Yield
  • EYEN N/A
  • PBM N/A
  • EPS Growth
  • EYEN N/A
  • PBM N/A
  • EPS
  • EYEN N/A
  • PBM N/A
  • Revenue
  • EYEN $31,832.00
  • PBM N/A
  • Revenue This Year
  • EYEN $23,413.60
  • PBM N/A
  • Revenue Next Year
  • EYEN $400.98
  • PBM N/A
  • P/E Ratio
  • EYEN N/A
  • PBM N/A
  • Revenue Growth
  • EYEN 2557.10
  • PBM N/A
  • 52 Week Low
  • EYEN $0.06
  • PBM $1.51
  • 52 Week High
  • EYEN $2.57
  • PBM $593.25
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 35.58
  • PBM 39.22
  • Support Level
  • EYEN $0.06
  • PBM $1.61
  • Resistance Level
  • EYEN $0.09
  • PBM $2.25
  • Average True Range (ATR)
  • EYEN 0.03
  • PBM 0.22
  • MACD
  • EYEN 0.00
  • PBM 0.06
  • Stochastic Oscillator
  • EYEN 1.58
  • PBM 23.38

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: